Share on Pinterest An experimental CRISPR-based gene editing treatment significantly improved vision outcomes in subjects with a rare eye disorder. Robert Nickelsberg/Getty Images Researchers from ...

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...

Binocular vision disorders encompass a range of conditions that impair the coordinated function of the eyes, detrimentally affecting the ability to focus, process depth and maintain visual comfort.

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first FDA-authorized protein-splicing therapy SB-007 in phase 1/2 testing. Encelto, an ...

For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the world through a straw hole, and in dimly lit places, she could not make ...

In the "ThemenCheck Medizin" procedure offered by the German Institute for Quality and Efficiency in Health Care (IQWiG), interested members of the public can submit proposals for the assessment of ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...

A revolutionary gene therapy treatment in London has improved the vision of children suffering from a rare genetic disorder, offering hope to families worldwide. Among the first to benefit from the ...

Here’s what to know about the irreversible eye disease at the center of the new National Geographic documentary Blink. Retinitis pigmentosa is a rare visual disorder that affects a layer of tissue in ...

Light sensitivity in one eye could occur for many reasons, ranging from minor injuries, dry eye, and migraine to more serious conditions, such as multiple sclerosis. Light sensitivity, or photophobia, ...